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Antimicrobial Resistance of Escherichia coli isolated in one day old 29 




The use of antimicrobials in food animals is the major determinant for the propagation of 34 
resistant bacteria in the animal reservoir. However, other factors also play a part. In particular, 35 
vertical spread between the generations has been suggested to be an important transmission 36 
pathway. The objective of this paper was to determine the resistance patterns of E. coli isolated 37 
from farmed newborn chickens as well as to study the antibiotic pressure effect when 38 
amoxicillin was administered during their growing period. With this aim, meconium from 22 39 
one day old Ross chickens was analyzed. In addition, during their growth period, amoxicillin 40 
treatments on days 7, 21 and 35 were carried out. Results showed a high number of E.coli 41 
resistant strains isolated from one day chickens, being the highest rates for beta-lactams group, 42 
followed by quinolone and tetracyclines. Moreover, as expected, analysis during the productive 43 
cycle of chickens after treatment with amoxicillin showed that the highest percentage of 44 
resistances were detected for this antibiotic. Moreover, significant differences in resistance 45 
percentages between control and treated broilers were detected in relation to ampicillin, 46 
cephalothin streptomycin, kanamycin, gentamicin, chloramphenicol and tetracycline. 47 
Differences in resistances to ciprofloxacin and nalidixic acid between control and treated 48 
animals were not observed. Finally, no resistance was detected for amikacin and ceftriaxone. 49 
These results suggest the possibility of vertical transmission of resistant strains to newborn 50 
chickens from parenteral flocks, and seem to indicate that the treatment with amoxicillin had a 51 
cross effect, increasing the resistances of E. coli to other antibiotics.  52 
 53 




1. Introduction 56 
 57 
Antimicrobial resistance is a main concern, since resistant bacteria can pose a greater 58 
risk to human health as a result of potential treatment failure, loss of treatment options 59 
and increased likelihood and severity of disease. In fact, treatment failures by 60 
multiresistant strains are responsible for half of the approximately 27,000 annual deaths 61 
from infections in the European Union (Watson, 2008).  62 
The use of antimicrobials drugs to treat and prevent diseases in animals or to 63 
promote their growth has been accompanied by the development of antimicrobial 64 
resistances. Transmission of resistance from animals to humans can take place through a 65 
variety of routes, where the food-borne route probably is the most important. Reduction 66 
in the use of antimicrobial agents can have a positive effect on the occurrence of 67 
antimicrobial resistance in humans and nowadays, the use of sub-therapeutic doses in 68 
order to increase the body weight is completely banned in the European Union since 69 
January 2006 (Regulation 1831/2003/EC).  70 
Resistant strains selected by animal antimicrobial treatments can reach humans via 71 
other animals, sewage, or other humans, such as farmers or slaughterers (Phillips et al., 72 
2003, Miranda, et al., 2007). Thus, transmission of resistant isolates between animals 73 
and environment makes necessary go ahead and invest in preventive measures. In this 74 
sense, addressing zoonotic transmission of pathogens that are resistant to antimicrobials 75 
is crucial to stablish effectice risk management policies.  76 
Amoxicillin (AMX) is a broad spectrum-lactam penicillin, introduced in human 77 
medicine in the early 1970s and used for the treatment of infections caused by Gram 78 
negative and positive bacteria. In fact, AMX is recommended by the European 79 
guidelines as the first-choice antibiotic for treating mild respiratory and other common 80 
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infections in non-hospitalized patients. For all these reasons, when investigating 81 
resistance spreading among farm animals, amoxicillin is one of the most interesting 82 
antibiotics to study.  83 
On the other hand, poultry was the most dynamic meat sector during the last decade. 84 
In fact, the total poultry meat production increased from 69 million tons in 2000 to 94 85 
million tons in 2008, which corresponds to an increase of 35% (FAO, 2010). Nowadays, 86 
this kind of meat represents 30% of the global meat consumption and chickens, 87 
followed by far for turkeys, are the most common sources of poultry meat (87% and 88 
6.7%, respectively) (FAO, 2010).  89 
Surveillance of resistance in commensal bacteria is important because they can be 90 
reservoirs of resistance determinants and because they are more ubiquitous than 91 
pathogens. Exchange of resistance genes occurs between pathogens and nonpathogens, 92 
even between gram-positive and gram-negative organisms. Of particular interest are 93 
enterococci and E. coli, that can play a role in transmission of mobile resistance genes 94 
(McEwen and Fedorka-Cray, 2002). E. coli isolated in healthy animals, carcasses or 95 
meat thereof, provides valuable data for investigating relationship with the selective 96 
pressure exerted by the use of antimicrobials on the intestinal population of bacteria in 97 
food-producing animals and determining the occurrence of resistance to antimicrobials. 98 
E. coli is also useful as representative of Enterobacteriaceae to monitor the emergence 99 
and changes in the proportion of bacteria possessing ESBL (EFSA 2013).  100 
Therefore, the objective of this paper was to determine the antibiotic resistances 101 
pattern of E. coli in newborn chicken, in order to assess the possibility of vertical 102 
transmission from parenteral flocks, and to study the antibiotic pressure effect that the 103 
administration of amoxicillin through their growth has in the development of 104 




2. Materials and methods 107 
 108 
2.1.  Breeding chickens 109 
A total of one day old 22 healthy Ross male chickens were obtained from the same 110 
commercial hatchery. Reception of chickens was carried out in the “Centro de 111 
Investigación Tecnológica Animal” in Segorbe, Castellón (Spain). Chickens were 112 
labeled and randomly assigned to six groups of three chickens and one with four chicks. 113 
Each group was conducted separately and between-group transmission was avoided by 114 
having a solid separation between pens. All the pens had a trough and three water nipple 115 
dispensers and the floor was covered with 10 cm of wood shavings. The chickens were 116 
fed with the same free-antimicrobial feed. All parts of this study were carried out 117 
according to EC council directives (2010/63/EU) concerning the laws, regulations, and 118 
administrative provisions of the member states regarding the protection of animals used 119 
for experimental and other scientific purposes (2015/VSC/PEA/00178).  120 
 121 
2.2.  Antibiotic administration 122 
One of the groups (the one with four chicks) was considered the control and was kept 123 
untreated. The six remaining groups were treated with amoxicillin (Neudiaval oral 124 
powder (50x118 g Laboratory Mevet, Lérida, Spain) according to manufacturer’s 125 
instructions. Chickens were kept in the experimental facilities from day of arrival (day 126 
0) until day of slaughter (day 49) and they were weighed and treated with different 127 
doses of amoxicillin: D1, 24 mg amoxicillin/kg of animal; D2, 12 mg amoxicillin/kg of 128 
animal and D3, 8 mg amoxicillin/kg of animal. Each dose was administered to two 129 
different groups. Dose administration was carried out with an oral syringe. The 130 
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treatments (T) were administered over 3 days. The treatment one (T1) started in day 7, 131 
treatment two (T2) day 21 and treatment three (T3) day 35 of chickens life cycle. No 132 
other antimicrobial treatment was administered during the course of the experiment. 133 
 134 
2.3.  Sample collection 135 
Four sample collections were carried out during the experimental period, 136 
immediately before administration of antibiotic doses. First sampling was on day 0 on 137 
meconia. Second and third samplings took place on days 21 and 35. Samples were taken 138 
directly from the cloaca using a sampling swab (Deltalab Collection and transport 139 
system. Amies swab ps+viscose). The final sampling was on day 49 and samples were 140 
taken directly from the cecum after slaughtering all the animals with over-doses with 141 
embutramide. In all cases, the samples were refrigerated until they were processed in 142 
the laboratory. 143 
 144 
2.4.  Escherichia coli isolation 145 
TBX agar plates (T.B.X. Medium, OXOID Ltd., England, UK) were inoculated and 146 
incubated at  44ºC for 24h. Two randomized colonies of each plate were isolated, 147 
transferred to PC agar (Plate Count Agar, Scharlau, Barcelona, Spain) and incubated to 148 
37ºC for 24h. The isolates from the PC agar plates were then checked as E. coli with the 149 
API-20 E system (Biomérieux, France). Colonies identified as E. coli were selected for 150 
the antibiogram test. 151 
 152 
2.5.  Antimicrobial susceptibility 153 
Antimicrobial susceptibility determination of isolated E. coli was completed by a 154 
standard disc diffusion assay (Antimicrobial Susceptibility Test Disc, OXOID Ltd., 155 
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England, UK) on Mueller Hinton agar (BBLTM Mueller-Hinton II Agar, BD).  The MIC 156 
breakpoints and levels of resistance were determined according to the recommendations 157 
of the Clinical Laboratory Standards Institute (CLSI, formerly NCCLS, 2002). The E. 158 
coli strains were tested against 12 antibiotics of veterinary and sanitary significance: 159 
gentamycin (CN) 10μg, amoxicillin/clavulamic acid (AMC) 3μg, ampicillin (AMP) 160 
10μg, amikacin (AK) 30μg, kanamycin (K) 30μg, cloranphenicol (C) 30μg, cephalothin 161 
(KF) 30μg, ciprofloxacin (CIP) 5μg, ceftriaxone (CRO) 30μg, tetracycline (TE) 30μg, 162 
nalidixic acid (NA) 30μg and streptomycin (S) 10μg. 163 
 164 
2.6.  Statistical analysis 165 
Statistical analyses of the data were undertaken using Statgraphics Centurion XVI.II 166 
(Statpoint Technologies, Inc. Warrenton, Virginia). The possible relationship between 167 
treatments with amoxicillin and the increase of E. coli resistance to different groups of 168 
antibiotics were carried out with a Multiple Correspondence Analysis (MCA) 169 
(Greenacre, 2007). In MCA, subjects (rows) and variables (columns) can be depicted 170 
simultaneously on a graphical display; where a close position between different points 171 
indicates a relatively high level of association. On the contrary, when the points are in 172 
different parts of the axis, the association is low. Relative proportions were compared 173 
using the Chisquared test (X2) and Fisher's exact test. Comparisons of means were also 174 
performed. A probability value of less than 5% was deemed to be significant.  175 
 176 
3. Results and discusion 177 
 178 
3.1. Resistances found in in one-day-old chickens 179 
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E. coli strains isolated from one-day-old chicks’ meconium showed resistance in 180 
63.3% (14 out of 22) and multiresistance, defined as resistance to at least three different 181 
antimicrobial classes, was observed in 95% (13 out of 14 meconia). The highest 182 
percentage of resistance was found against nalidixic acid (80%), ampicillin, and 183 
amoxicillin/clavulanic, both of them in 70% of samples, followed by tetracycline (30%) 184 
cephalothin (23.3%) and ciprofloxacin (16.7%). Lower than 10% resistances were 185 
found against streptomycin, gentamicin and kanamycin. Finally, none of the E. coli 186 
isolates was resistant to amikacin, chloramphenicol and ceftriaxone (Figure 1). Similar 187 
results were found by Martins da Costa et al. (2011) who found no E. coli resistant to 188 
chloramphenicol but observed resistant strains from one day-old-chicks against 189 
ampicillin, cephalothin, tetracycline, streptomycin, gentamicin and enrofloxacin. As this 190 
study was performed from chickens that had not been exposed to antimicrobial agents 191 
previously, a vertical transmission of resistant strains from parental flocks (Giovanardi 192 
et al., 2005a; 2005b) or by contamination in the hatchery environment (Dierikx et al., 193 
2013) could be the main causes. In our work, environmental exposition to antibiotics 194 
was limited by the conditions of expertimental design: “Centro de Investigación 195 
Tecnológica Animal” is not a conventional, but an experimental farm, in which 196 
chickens were maintained into high hygienic pens, thus reducing as much as possible 197 
the spreading of antibiotic exposure through environment. Thus, contamination of 198 
chickens via vertical transmission seems to be the most probable explanation to the high 199 
resistance rates found. 200 
According to Petersen et al. (2006) parents represent an extensive bacterial reservoir 201 
from which transmission may occur through contamination of the eggs shell during lay. 202 
The study performed by Bortolaia et al. (2010) was also consistent with vertical 203 
transmission of ampicillin and nalidixic acid resistant E. coli through the broiler 204 
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production system. These authors concluded that clones among parent and broiler flocks 205 
were indistinguishable, which indicated that transmission of ampicillin and nalidixic 206 
resistant E. coli occurred from parents to broilers. Bortolaia et al (2010) suggested, 207 
according to their findings, that resistance to beta-lactams and fluoro-quinolone in E. 208 
coli was due to vertical transmission through parent chickens. In the same framework, 209 
Baron et al. (2014) suggested that E. coli resistance may be introduced in the hatchery 210 
facilities, either form true vertical transmission when parental poultry stocks are 211 
contaminated or form very early contamination in the hatchery itself, or during 212 
transport, which is a period when the immature digestive flora is probably very 213 
receptive to early colonization, although other possible contamination events occurring 214 
thereafter on the production farm cannot be excluded.  215 
 216 
3.2. Resistances patterns changes during experimental treatments with amoxicillin 217 
During the growth period, three amoxicillin treatments were administrated. Results 218 
of resistant E. coli isolated strains showed no significant differences between them (p-219 
value 0,1760), however, significant differences were found between isolates from 220 
control and treated broilers (p-value 0,0013). Finally, no significant differences existed 221 
in the resistances found between the three doses administrated (p-value 0.9025), 222 
consequently, values from the three doses were managed together.  223 
Figure 2 shows the Multiple Correspondence Analysis (MCA) carried out to evaluate 224 
the global effect of each amoxicillin treatments on the profile of E. coli response 225 
(sensitive, intermediate and resistant) to different groups of antibiotics used. Two 226 
dimensional MCA solution accounts for 23.6% of the inertia (the first dimension 227 
accounts for 15.1% and the second 8.5%). Considering the x-axis, resistance and 228 
intermediate resistance of E. coli to antibiotics were located on the left; however, 229 
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antibiotic sensitivity was located on the right. Moreover, considering that the closer 230 
position the closer relationship, results showed that control samples had a higher 231 
percentage of E. coli strains sensitive to antibiotics and those obtained from chicken 232 
treated had a higher percentage of resistances. In addition, the antibiotics more related 233 
with resistance response were ampicillin, amoxicillin, cephalothin, which means that 234 
although only one antibiotic was used, it could be influencing other  lactam antibiotics. 235 
On the other hand of the axis, corresponding to antimicrobial sensitive response, 236 
ceftriaxone, kanamicin, gentamicin, ciprofloxacin and chloranphenicol presented a near 237 
position and consequently a high antimicrobial sensitivity. Considering the y-axis, 238 
fewer differences can be observed. However, the high distance of intermediate response 239 
indicates a low percentage of intermediate resistance. 240 
Figure 3 shows the relationship between broiler chickens treatment with amoxicillin 241 
and antimicrobial resistance of E. coli to beta-lactams (amoxicillin, ampicillin, 242 
ceftriaxone and cephalothin); aminoglycosides (amikacin, gentamicyn, kanamycin and 243 
streptomycin); phenicol (chloranphenicol); quinolones (ciprofloxacin and nalidixic acid) 244 
and tetracycline (tetracycline).  245 
Results showed that no animal (control and treated) presented E. coli strains resistant 246 
to amikacin and ceftriaxone. Similar results were found by Saenz et al. (2001) and 247 
Bywater et al. (2004). Taking into account the critical importance for human medicine 248 
of ceftriaxone (WHO, 2012; Domenech et al., 2015) the obtained results are 249 
encouraging.  250 
Slight differences in resistances between control and treated flocks were found for  251 
ciprofloxacin and nalidixic acid. In addition, antimicrobial resistance in control birds 252 
(not exposed to antimicrobials) exhibited interesting changes over time in ciprofloxacin. 253 
In this cases, no resistant strains are present in control 1 (C1), corresponding to day 7 of 254 
12 
 
life cycle, however they appear in controls 2 and 3. In a previous study, Apajalahti et 255 
al., (2004), reported that microbial composition of the chicken gut can change according 256 
to the diet and the environment, directly by providing a continuous source of bacteria, 257 
or indirectly by influencing bird defense mechanisms. In general, a large numbers of 258 
chicks bearing resistant E. coli strains shed huge numbers of resistant isolates, resulting 259 
in rapid contamination of the other individuals in the same flock and production barn 260 
environment. This high level of contamination is probably difficult to eliminate even 261 
with strict disinfection procedures, particularly on farms with outdoor runs (Baron et al., 262 
2014). 263 
In this work, obtained values for resistance to nalidixic acid in treated chickens were 264 
64±8.2% . The resistance rates of E. coli reported by EFSA, (2013) vary considerably 265 
between countries, from 0.6%, (n= 316) in Finland to 85.1% (n= 101 samples) in Spain. 266 
In relation to ciprofloxacin, obtained values were 16.1±4.8%. These values are higher 267 
than those reported in Denmark 9% ( n=134 samples), and lower that the European 268 
mean 53.1 % (n=1703) (EFSA, 2013). 269 
On the other hand, resistant E. coli to ampicillin, cephalothin, all aminoglycosides 270 
studied, chloramphenicol and tetracycline showed high differences between treated and 271 
no treated flocks. Moreover, only treated animals presented resistance to gentamicin, 272 
kanamycin streptomycin and chloramphenicol. When an antibiotic pressure is acting, 273 
those genes that are capable to permit the survival of the strains are selected. These 274 
selected genes can be horizontally transferred between different bacterial species (Van 275 
den Bogaard et al., 2001). Horizontal gene transfer is the most characteristic acquisition 276 
of resistance genes (Binnewies et al. 2006). Plasmids carrying genetic determinants 277 
which confer resistance to different classes of antibiotics confer a selective advantage 278 
for the carrier strains. This kind of plasmids are large, self-conjugative and control their 279 
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copy number by regulation of the replication rate in the cell (Nordstrom, 2005), what 280 
could lead to their persistence and spread in the microbial community of the intestine. 281 
Moreover, a study carried by Miller et al. (2004) showed that the exposure to beta-282 
lactams induce the dpiBA operon, which inhibits the replication of the bacterial 283 
chromosome, inducing the SOS response and induce an enhancement of the genetic 284 
variability. These facts could explain the general higher rates of resistance for the 285 
treated group versus the control group.  286 
The higher resistance rates for tetracyclines determined in this work was 67.6%, 287 
although the mean value was 37.4%. These values were relatively low as compared with 288 
a 75% of resistance reported by Sáenz et al., (2001) and was around the European mean 289 
value reported by EFSA, 2013 45.2% (n=2019). Multiresistant strains were more 290 
prevalent in each successive trial. This might be explained by the persistence of farm 291 
indigenous E. coli strains that were repeatedly exposed to antimicrobials (Furtula et al., 292 
2010; Smith et al., 2007). 293 
With regard to public health, amoxicillin, ampicillin, and nalidixic acid are on the list 294 
of Critically Important Antimicrobials published by the WHO Advisory Group on 295 
Integrated Surveillance of Antimicrobial Resistance (WHO, 2012), by acomplishing the 296 
criterion 1 (the antimicrobial agent is the sole, or one of limited available therapy, to 297 
treat serious human disease) and also the criterion 2 (Antimicrobial agent is used to treat 298 
diseases caused by either: (a) organisms that may be transmitted to humans from non-299 
human sources or, (b) human diseases causes by organisms that may acquire resistance 300 
genes from non-human sources). Hence, the increasing of antimicrobial resistance in 301 
general and resistance to these antibiotics in particular, may represent a major threat to 302 
human health (EU Commission, 2010).  303 
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To conclude, in this work we have demonstrated the existence of a high percentage 304 
of resistant E. coli strains in one old day chickens, not exposed previously to any 305 
antibiotic, what strongly suggest the possibility of vertical transmission from parenteral 306 
flocks. On the other hand, influence of amoxicillin treatments in increasing resistances 307 
to beta-lactams, aminoglycosides and cloramphenicol has been shown. Critical 308 
importance to human health of the antimicrobial resistances found highlights the 309 
importance to take immediately control measures focusing on reducing vertical and 310 
horizontal transmission in farm environment.  311 
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Figure captions 406 
 407 
Figure 1. Percentage of E. coli resistant resistant ( ), intermediate ( ) and sensitive  408 
(  ) in meconia of day-old chicks. Where AK= Amikacin; AMC= Amoxicilin/ 409 
clavulamic acid; AMP=Ampicillin; C= Chloramphenicol; CIP= Ciprofloxacin; CN= 410 
Gentamicin; CRO= Ceftriaxone; K= Kanamycin; KF= Cephalothin; NA= Nalidixic 411 
acid; TE= Tetracycline; S= Streptomycin 412 
 413 
Figure 2. MCA bi-plot. Antibiotics tested: A. AMP =Ampicillin; A. C = 414 
Chloramphenicol; A. CN = Gentamicin; A. CRO = Ceftriaxone; A. K= kanamycin; A. 415 
NA = Nalidixic acid; A. SXT = Trimethoprim/sulphametoxazol; A. TE = Tetracycline. 416 
Before any dose administrations (C0), after the three dose administrations (T1, T2 and 417 
T3), and the same sampling for the control group (C1, C2, C3). VR = (resistant), VI = 418 
(intermediate), VS = (sensitive). 419 
 420 
Figure 3: Percentage of E. coli resistant ( ), intermediate ( ) and sensitive  (    ) for 421 
the group of control (C1, C2, and C3) and after the three treatments (T1, T2 and T3). 422 
Where AK= Amikacin; AMC= Amoxicilin/ clavulamic acid; AMP=Ampicillin; C= 423 
Chloramphenicol; CIP= Ciprofloxacin; CN= Gentamicin; CRO= Ceftriaxone; K= 424 
Kanamycin; KF= Cephalothin; NA= Nalidixic acid; TE= Tetracycline; S= Streptomycin 425 
 426 
